European Society of Cataract and Refractive Surgeons (ESCRS) September 5, 2010 Filed under: Trends-in-Medicine
FDA Restricts Use of GSK's Avandia While European Regulators Ban Use September 5, 2010 Filed under: Trends-in-Medicine
FDA Advisory Committee Recommends Approval of AstraZeneca's Antiplatelet Agent Brilinta Despite Troublesome Data on U.S. Patients September 5, 2010 Filed under: Trends-in-Medicine
FDA Advisory Committee Recommends Either Serious Restrictions on Use of Withdrawal of GSK's Avandia August 2, 2010 Filed under: Trends-in-Medicine
FDA Proposes Changes to 510(k) Program for Medical Device Approvals August 2, 2010 Filed under: Trends-in-Medicine